PTC Therapeutics Quarterly Balance Sheets Chart
Quarterly
|
Annual
PTC Therapeutics Quarterly Balance Sheets Table
Quarterly
|
Annual
| Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-09-30 | 2015-06-30 | 2015-03-31 | 2014-09-30 | 2014-06-30 | 2014-03-31 | 2013-09-30 | 2013-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| assets | ||||||||||||||||||||||||||||||||||||||||||||||
| current assets: | ||||||||||||||||||||||||||||||||||||||||||||||
| cash and cash equivalents | 1,017,386,000 | 1,480,231,000 | 779,709,000 | 526,001,000 | 654,779,000 | 548,355,000 | 594,001,000 | 165,157,000 | 208,393,000 | 167,495,000 | 279,834,000 | 104,424,000 | 158,158,000 | 144,178,000 | 189,718,000 | 189,818,000 | 177,347,000 | 146,632,000 | 208,812,000 | 433,970,000 | 158,461,000 | 123,287,000 | 288,028,000 | 523,577,000 | 136,094,000 | 201,144,000 | 169,498,000 | 206,913,000 | 223,788,000 | 97,675,000 | 111,792,000 | 141,838,000 | 133,011,000 | 54,106,000 | 58,321,000 | 50,286,000 | 35,658,000 | 40,165,000 | 140,712,000 | 29,220,000 | 36,825,000 | 52,873,000 | 21,172,000 | 115,855,000 | 24,044,819 | 154,095,269 |
| marketable securities | 971,764,000 | 546,950,000 | 359,987,000 | 487,356,000 | 438,514,000 | 336,458,000 | 282,738,000 | 129,653,000 | 129,550,000 | 118,808,000 | 130,871,000 | 184,008,000 | 347,387,000 | 443,615,000 | 583,658,000 | 678,125,000 | 769,734,000 | 841,774,000 | 894,838,000 | 707,049,000 | 340,430,000 | 472,572,000 | 398,535,000 | 185,072,000 | 227,447,000 | 206,018,000 | 58,088,000 | 42,491,000 | 72,318,000 | 80,595,000 | 79,454,000 | 27,472,000 | 48,058,000 | 148,471,000 | 173,345,000 | 198,052,000 | 237,235,000 | 258,547,000 | 230,809,000 | 225,999,000 | 243,642,000 | 156,516,000 | 205,687,000 | 130,730,000 | 133,182,565 | 11,582,786 |
| trade and royalty receivables | 196,133,000 | 210,495,000 | 158,554,000 | 199,976,000 | 187,150,000 | 197,660,000 | 160,822,000 | 165,718,000 | 177,503,000 | 201,867,000 | 155,614,000 | 124,456,000 | 135,943,000 | 141,288,000 | 110,455,000 | |||||||||||||||||||||||||||||||
| inventory | 34,061,000 | 21,675,000 | 23,194,000 | 35,671,000 | 31,826,000 | 30,058,000 | 30,577,000 | 35,752,000 | 32,018,000 | 26,649,000 | 21,808,000 | 14,812,000 | 15,004,000 | 15,281,000 | 15,856,000 | 15,613,000 | 16,441,000 | 16,234,000 | 18,697,000 | 19,481,000 | 18,373,000 | 19,133,000 | 19,285,000 | 17,107,000 | 16,897,000 | 16,219,000 | 16,117,000 | 13,660,000 | 13,852,000 | 12,355,000 | 10,754,000 | 7,792,000 | 6,912,000 | 1,354,000 | ||||||||||||
| prepaid expenses and other current assets | 53,531,000 | 57,055,000 | 44,087,000 | 32,546,000 | 45,641,000 | 56,207,000 | 150,491,000 | 44,082,000 | 42,227,000 | 98,573,000 | 105,658,000 | 89,562,000 | 38,184,000 | 29,647,000 | 54,681,000 | 30,939,000 | 23,910,000 | 23,601,000 | 39,469,000 | 26,888,000 | 34,116,000 | 24,307,000 | 17,898,000 | 20,723,000 | 17,424,000 | 9,348,000 | 9,247,000 | 8,020,000 | 6,305,000 | 5,760,000 | 6,669,000 | 5,413,000 | 5,224,000 | 4,623,000 | 4,691,000 | 4,860,000 | 4,776,000 | 5,104,000 | 4,627,000 | 4,241,000 | 6,116,000 | 2,831,000 | 2,597,000 | 1,957,000 | 2,126,575 | 1,609,382 |
| total current assets | 2,272,875,000 | 2,316,406,000 | 1,365,531,000 | 1,281,550,000 | 1,357,910,000 | 1,168,738,000 | 1,218,629,000 | 540,362,000 | 589,691,000 | 613,392,000 | 693,785,000 | 517,262,000 | 694,676,000 | 774,009,000 | 954,368,000 | 1,011,140,000 | 1,066,233,000 | 1,122,365,000 | 1,231,745,000 | 1,244,174,000 | 605,024,000 | 691,922,000 | 779,284,000 | 806,862,000 | 474,966,000 | 479,079,000 | 320,857,000 | 313,281,000 | 375,646,000 | 241,996,000 | 249,063,000 | 221,259,000 | 226,972,000 | 240,727,000 | 261,286,000 | 280,607,000 | 297,434,000 | 326,434,000 | 384,164,000 | 264,574,000 | 289,761,000 | 213,516,000 | 230,314,000 | 249,380,000 | 160,137,810 | 168,158,078 |
| fixed assets | 57,189,000 | 59,459,000 | 60,970,000 | 63,175,000 | 65,987,000 | 92,779,000 | 87,089,000 | 85,031,000 | 82,129,000 | 79,492,000 | 72,590,000 | 66,889,000 | 64,913,000 | 59,088,000 | 52,585,000 | 46,354,000 | 42,910,000 | 37,123,000 | 33,831,000 | 28,141,000 | 26,806,000 | 26,169,000 | 21,549,000 | 18,484,000 | 15,391,000 | 14,540,000 | 12,694,000 | 8,805,000 | 8,217,000 | 8,302,000 | 8,376,000 | 6,882,000 | 6,839,000 | 7,059,000 | 7,429,000 | 7,059,000 | 7,601,000 | 8,426,000 | 8,799,000 | 9,017,000 | 9,408,000 | 6,193,000 | 6,417,000 | 6,328,000 | 6,942,956 | 7,153,532 |
| intangible assets | 143,806,000 | 118,448,000 | 118,794,000 | 330,368,000 | 329,879,000 | 330,040,000 | 379,497,000 | 423,342,000 | 451,629,000 | 686,205,000 | 705,891,000 | 749,890,000 | 760,154,000 | 763,665,000 | 724,841,000 | 723,260,000 | 717,079,000 | 712,574,000 | 715,328,000 | 712,536,000 | 708,814,000 | 705,294,000 | 710,500,000 | 702,910,000 | 702,729,000 | 694,955,000 | 701,031,000 | 604,612,000 | 126,290,000 | 127,565,000 | 132,993,000 | 138,422,000 | 148,138,000 | |||||||||||||
| goodwill | 82,341,000 | 82,341,000 | 82,341,000 | 82,341,000 | 82,341,000 | 82,341,000 | 82,341,000 | 82,341,000 | 82,341,000 | 82,341,000 | 82,341,000 | 82,341,000 | 82,341,000 | 82,341,000 | 82,341,000 | 82,341,000 | 82,341,000 | 82,341,000 | 82,341,000 | 82,341,000 | 82,341,000 | 82,341,000 | 82,341,000 | 82,341,000 | 82,341,000 | 82,341,000 | 82,341,000 | 100,309,000 | ||||||||||||||||||
| operating lease rou assets | 56,162,000 | 57,317,000 | 56,685,000 | 59,465,000 | 57,135,000 | 91,186,000 | 91,896,000 | 94,072,000 | 96,686,000 | 99,531,000 | 102,430,000 | 104,901,000 | 141,635,000 | 76,093,000 | 77,421,000 | 78,699,000 | 80,694,000 | 82,382,000 | 85,810,000 | |||||||||||||||||||||||||||
| deposits and other assets | 21,782,000 | 21,416,000 | 20,703,000 | 25,337,000 | 23,103,000 | 24,545,000 | 36,246,000 | 34,737,000 | 35,648,000 | 47,878,000 | 48,582,000 | 55,115,000 | 60,338,000 | 44,395,000 | 46,500,000 | 65,531,000 | 69,412,000 | 75,156,000 | 60,623,000 | 28,057,000 | 53,652,000 | 39,866,000 | 30,108,000 | 30,889,000 | 16,145,000 | 12,996,000 | 2,299,000 | 1,620,000 | 1,620,000 | 1,548,000 | 1,221,000 | 1,157,000 | 1,129,000 | 859,000 | 630,000 | 511,000 | 528,000 | 372,000 | 3,137,000 | 231,000 | 351,000 | 1,086,000 | 827,000 | 132,000 | 163,349 | 156,474 |
| total assets | 2,634,155,000 | 2,655,387,000 | 1,705,024,000 | 1,842,236,000 | 1,916,355,000 | 1,789,629,000 | 1,895,698,000 | 1,259,885,000 | 1,338,124,000 | 1,608,839,000 | 1,705,619,000 | 1,576,398,000 | 1,804,057,000 | 1,799,591,000 | 1,938,056,000 | 2,007,325,000 | 2,058,669,000 | 2,111,941,000 | 2,208,278,000 | 2,181,059,000 | 1,476,637,000 | 1,545,592,000 | 1,623,782,000 | 1,641,486,000 | 1,291,572,000 | 1,283,911,000 | 1,119,222,000 | 1,028,627,000 | 511,773,000 | 379,411,000 | 391,653,000 | 367,720,000 | 383,078,000 | 248,645,000 | 269,345,000 | 288,177,000 | 305,563,000 | 335,232,000 | 396,100,000 | 273,822,000 | 299,520,000 | 220,795,000 | 237,558,000 | 255,840,000 | 167,244,115 | 175,468,084 |
| liabilities and stockholders’ deficit | ||||||||||||||||||||||||||||||||||||||||||||||
| current liabilities: | ||||||||||||||||||||||||||||||||||||||||||||||
| accounts payable and accrued expenses | 338,945,000 | 317,807,000 | 304,292,000 | 336,346,000 | 338,800,000 | 330,924,000 | 391,983,000 | 370,731,000 | 358,562,000 | 332,091,000 | 320,366,000 | 329,322,000 | 330,918,000 | 246,521,000 | 288,784,000 | 252,329,000 | 235,921,000 | 205,636,000 | 242,168,000 | 218,561,000 | 164,376,000 | 145,386,000 | 159,276,000 | 128,150,000 | 122,375,000 | 98,450,000 | 128,199,000 | 102,788,000 | 82,534,000 | 71,437,000 | 76,446,000 | 64,054,000 | 63,996,000 | 45,153,000 | 48,759,000 | 47,759,000 | 42,183,000 | 43,493,000 | 31,695,000 | 23,082,000 | 23,532,000 | 16,493,000 | 11,341,000 | 8,735,000 | 10,205,493 | 10,058,471 |
| deferred revenue | 9,760,000 | 12,833,000 | 5,505,000 | 801,000 | 1,224,000 | 214,000 | 1,351,000 | 1,887,000 | 4,151,000 | 5,992,000 | 7,702,000 | 8,638,000 | 8,242,000 | 8,810,000 | 8,005,000 | 5,497,000 | 3,716,000 | 2,004,000 | 3,937,000 | 6,122,000 | 2,602,000 | 910,000 | 726,000 | 396,000 | 373,000 | 769,000 | 242,000 | 492,000 | 3,631,430 | 6,983,506 | ||||||||||||||||
| operating lease liabilities- current | 11,725,000 | 11,464,000 | 10,363,000 | 14,113,000 | 13,714,000 | 14,572,000 | 13,002,000 | 11,703,000 | 10,199,000 | 9,598,000 | 9,370,000 | 8,895,000 | 8,898,000 | 7,369,000 | 7,273,000 | 7,144,000 | 7,335,000 | 7,333,000 | 5,859,000 | |||||||||||||||||||||||||||
| finance lease liabilities- current | 5,358,000 | 5,047,000 | 3,000,000 | 2,642,000 | 2,292,000 | 1,948,000 | 3,000,000 | 2,611,000 | 2,230,000 | 1,857,000 | 3,000,000 | 2,583,000 | 2,174,000 | 1,772,000 | 3,000,000 | 2,557,000 | 2,121,000 | 1,694,000 | 1,251,000 | 4,180,000 | ||||||||||||||||||||||||||
| liability for sale of future royalties- current | 262,021,000 | 248,240,000 | 257,821,000 | 257,611,000 | 254,997,000 | 227,102,000 | 194,314,000 | 105,849,000 | 105,351,000 | 97,874,000 | 72,149,000 | 77,964,000 | 74,022,000 | 69,943,000 | 59,291,000 | 52,651,000 | 44,335,000 | 33,149,000 | 22,159,000 | |||||||||||||||||||||||||||
| total current liabilities | 627,809,000 | 595,391,000 | 580,981,000 | 610,712,000 | 609,803,000 | 574,546,000 | 603,100,000 | 492,118,000 | 476,342,000 | 441,634,000 | 406,236,000 | 420,076,000 | 567,371,000 | 476,776,000 | 509,348,000 | 465,261,000 | 290,962,000 | 250,949,000 | 277,333,000 | 253,822,000 | 201,843,000 | 217,668,000 | 235,857,000 | 183,500,000 | 173,959,000 | 143,046,000 | 166,796,000 | 114,922,000 | 86,474,000 | 72,716,000 | 82,048,000 | 71,899,000 | 67,985,000 | 45,418,000 | 49,624,000 | 48,926,000 | 42,909,000 | 43,889,000 | 31,695,000 | 23,082,000 | 23,905,000 | 17,262,000 | 11,583,000 | 9,239,000 | 13,921,157 | 19,788,489 |
| long-term debt | 286,013,000 | 285,712,000 | 285,412,000 | 285,106,000 | 284,806,000 | 284,512,000 | 284,213,000 | 573,174,000 | 572,643,000 | 572,091,000 | 571,722,000 | 282,749,000 | 282,460,000 | 282,176,000 | 281,894,000 | 281,604,000 | 430,496,000 | 430,038,000 | 309,145,000 | 302,971,000 | 297,029,000 | 294,574,000 | 293,859,000 | 293,149,000 | 135,683,000 | 138,468,000 | 141,347,000 | 144,258,000 | 147,204,000 | 146,878,000 | 144,971,000 | 143,091,000 | 141,242,000 | 99,895,000 | 98,216,000 | 96,559,000 | 94,936,000 | 93,366,000 | 93,198,000 | |||||||
| contingent consideration payable | 800,000 | 22,000,000 | 21,300,000 | 36,200,000 | 36,300,000 | 39,000,000 | 37,500,000 | 166,400,000 | 164,000,000 | 157,700,000 | 163,000,000 | 228,200,000 | 239,900,000 | 252,000,000 | 241,200,000 | 240,500,000 | 240,400,000 | 234,100,000 | 225,700,000 | 357,200,000 | 356,300,000 | 344,900,000 | 336,200,000 | 330,900,000 | 310,240,000 | 218,700,000 | ||||||||||||||||||||
| operating lease liabilities- noncurrent | 71,237,000 | 73,559,000 | 74,947,000 | 82,770,000 | 79,118,000 | 104,837,000 | 97,627,000 | 99,682,000 | 100,425,000 | 100,442,000 | 100,860,000 | 102,124,000 | 137,353,000 | 72,432,000 | 73,619,000 | 74,823,000 | 76,425,000 | 77,863,000 | 81,674,000 | |||||||||||||||||||||||||||
| finance lease liabilities- noncurrent | 13,833,000 | 13,833,000 | 15,574,000 | 15,574,000 | 15,574,000 | 15,574,000 | 17,184,000 | 17,184,000 | 17,184,000 | 17,184,000 | 18,675,000 | 18,675,000 | 18,675,000 | 18,675,000 | 20,053,000 | 20,053,000 | 20,053,000 | 20,053,000 | 22,608,000 | 22,031,000 | ||||||||||||||||||||||||||
| liability for sale of future royalties- noncurrent | 1,833,985,000 | 1,850,223,000 | 1,823,955,000 | 1,824,440,000 | 1,829,883,000 | 1,611,831,000 | 1,619,783,000 | 657,469,000 | 661,229,000 | 665,677,000 | 685,737,000 | 680,182,000 | 680,306,000 | 674,803,000 | 674,694,000 | 670,549,000 | 664,829,000 | 661,835,000 | 642,099,000 | |||||||||||||||||||||||||||
| other long-term liabilities | 7,824,000 | 22,429,000 | 21,426,000 | 77,000 | 141,000 | 141,000 | 141,000 | 141,000 | 141,000 | 141,000 | 2,641,000 | 4,686,000 | 1,376,000 | 1,392,000 | 1,392,000 | 1,392,000 | 1,968,000 | 26,678,000 | 14,786,000 | 9,159,000 | 9,455,000 | 8,416,000 | 8,770,000 | 58,000 | 101,000 | 153,000 | 209,000 | 243,000 | 269,000 | 292,000 | 311,000 | 335,000 | 2,515,000 | 2,094,000 | 1,976,000 | 2,056,000 | 2,159,000 | 2,295,000 | 2,237,000 | 2,219,000 | 2,259,000 | 2,290,445 | 2,518,288 | |||
| total liabilities | 2,840,701,000 | 2,841,147,000 | 2,803,095,000 | 2,896,588,000 | 2,896,536,000 | 2,683,545,000 | 2,714,253,000 | 1,930,695,000 | 1,917,392,000 | 2,066,400,000 | 2,052,705,000 | 1,803,302,000 | 1,986,275,000 | 1,890,172,000 | 1,936,618,000 | 1,902,399,000 | 1,862,092,000 | 1,819,365,000 | 1,726,296,000 | 1,670,105,000 | 904,143,000 | 1,016,858,000 | 1,029,452,000 | 977,832,000 | 802,887,000 | 770,969,000 | 768,495,000 | 642,537,000 | 244,371,000 | 229,103,000 | 235,216,000 | 221,838,000 | 213,347,000 | 147,818,000 | 149,762,000 | 148,000,000 | 139,939,000 | 139,231,000 | 126,949,000 | 25,241,000 | 26,200,000 | 19,499,000 | 13,802,000 | 11,498,000 | 16,211,602 | 22,548,444 |
| stockholders’ deficit: | ||||||||||||||||||||||||||||||||||||||||||||||
| common stock | 78,000 | 78,000 | 77,000 | 76,000 | 76,000 | 76,000 | 75,000 | 75,000 | 75,000 | 73,000 | 72,000 | 71,000 | 71,000 | 71,000 | 71,000 | 70,000 | 70,000 | 70,000 | 70,000 | 68,000 | 67,000 | 62,000 | 62,000 | 61,000 | 58,000 | 58,000 | 51,000 | 51,000 | 47,000 | 42,000 | 42,000 | 41,000 | 41,000 | 34,000 | 34,000 | 34,000 | 34,000 | 34,000 | 34,000 | 34,000 | 33,000 | 30,000 | 30,000 | 30,000 | 24,344 | 24,344 |
| additional paid-in capital | 2,631,180,000 | 2,608,422,000 | 2,574,611,000 | 2,530,902,000 | 2,510,574,000 | 2,486,722,000 | 2,466,233,000 | 2,447,292,000 | 2,416,904,000 | 2,339,886,000 | 2,305,020,000 | 2,222,905,000 | 2,184,230,000 | 2,152,639,000 | 2,123,606,000 | 2,092,534,000 | 2,063,687,000 | 2,033,972,000 | 2,171,746,000 | 2,101,136,000 | 2,067,274,000 | 1,834,061,000 | 1,795,351,000 | 1,775,799,000 | 1,539,530,000 | 1,523,115,000 | 1,288,137,000 | 1,275,004,000 | 1,105,124,000 | 975,418,000 | 966,534,000 | 958,206,000 | 949,331,000 | 865,834,000 | 856,142,000 | 847,700,000 | 837,850,000 | 829,114,000 | 812,294,000 | 747,869,000 | 734,489,000 | 596,617,000 | 591,636,000 | 587,128,000 | 461,960,966 | 459,391,899 |
| accumulated other comprehensive income | 7,356,000 | -1,285,000 | 9,609,000 | -1,431,000 | -1,587,000 | 4,796,000 | 36,205,000 | -38,743,000 | -60,957,000 | -35,727,000 | -10,016,000 | -1,985,000 | -10,584,000 | 616,000 | 1,922,000 | 805,000 | 1,462,000 | 1,628,000 | 1,855,000 | 4,953,000 | 3,969,000 | 3,013,000 | 1,999,000 | 756,000 | 885,000 | 1,084,000 | 90,000 | |||||||||||||||||||
| accumulated deficit | -2,845,160,000 | -2,780,311,000 | -3,646,873,000 | -3,580,987,000 | -3,474,333,000 | -3,375,154,000 | -3,283,578,000 | -3,127,786,000 | -2,994,816,000 | -2,795,933,000 | -2,656,974,000 | -2,486,085,000 | -2,376,770,000 | -2,224,683,000 | -2,097,957,000 | -1,954,717,000 | -1,821,093,000 | -1,702,723,000 | -1,628,877,000 | -1,554,523,000 | -1,484,831,000 | -1,303,404,000 | -1,190,499,000 | -1,112,822,000 | -1,052,825,000 | -1,011,036,000 | -938,923,000 | -890,593,000 | -839,624,000 | -830,105,000 | -814,108,000 | -815,378,000 | -781,640,000 | -764,165,000 | -735,108,000 | -708,313,000 | ||||||||||
| total stockholders’ deficit | -206,546,000 | -185,760,000 | -1,098,071,000 | -1,054,352,000 | -980,181,000 | -893,916,000 | -818,555,000 | -670,810,000 | -579,268,000 | -457,561,000 | ||||||||||||||||||||||||||||||||||||
| total liabilities and stockholders’ deficit | 2,634,155,000 | 2,655,387,000 | 1,705,024,000 | 1,842,236,000 | 1,916,355,000 | 1,789,629,000 | 1,895,698,000 | 1,259,885,000 | 1,338,124,000 | 1,608,839,000 | ||||||||||||||||||||||||||||||||||||
| accumulated other comprehensive loss | -13,949,000 | -25,886,000 | -4,343,000 | -16,498,000 | -5,560,000 | 10,251,000 | -18,608,000 | -24,282,000 | -32,961,000 | -46,087,000 | -876,000 | -1,485,000 | 80,000 | |||||||||||||||||||||||||||||||||
| deferred tax liability | 55,909,000 | 55,911,000 | 55,904,000 | 55,905,000 | 51,927,000 | 51,928,000 | 102,831,000 | 102,834,000 | 137,110,000 | 137,110,000 | 137,110,000 | 137,110,000 | 136,733,000 | 136,735,000 | 136,735,000 | 136,735,000 | 130,863,000 | 130,862,000 | 130,862,000 | 130,862,000 | 122,032,000 | 122,032,000 | 122,032,000 | 122,032,000 | 115,200,000 | |||||||||||||||||||||
| liabilities and stockholders’ (deficit) equity | ||||||||||||||||||||||||||||||||||||||||||||||
| current portion of long-term debt | 149,908,000 | 149,721,000 | 149,540,000 | 149,358,000 | 18,333,000 | 20,000,000 | 20,000,000 | 20,000,000 | 20,000,000 | 16,667,000 | 11,667,000 | 6,667,000 | 1,666,000 | 12,000 | 84,234 | 2,746,512 | ||||||||||||||||||||||||||||||
| other current liabilities | 1,312,000 | 1,451,000 | 1,450,000 | 1,460,000 | 1,222,000 | 1,250,000 | 1,250,000 | 4,868,000 | 3,644,000 | 8,339,000 | 6,840,000 | 4,179,000 | 3,132,000 | 3,814,000 | 3,463,000 | 2,274,000 | 1,279,000 | 1,665,000 | 1,723,000 | 1,387,000 | 265,000 | 865,000 | 257,000 | |||||||||||||||||||||||
| stockholders’ (deficit) equity: | ||||||||||||||||||||||||||||||||||||||||||||||
| total stockholders’ (deficit) equity | -347,086,000 | -226,904,000 | -182,218,000 | -90,581,000 | 151,032,513 | 152,919,640 | ||||||||||||||||||||||||||||||||||||||||
| total liabilities and stockholders’ (deficit) equity | 1,705,619,000 | 1,576,398,000 | ||||||||||||||||||||||||||||||||||||||||||||
| total liabilities and stockholders’ equity | 1,804,057,000 | 1,799,591,000 | 1,938,056,000 | 2,007,325,000 | 2,058,669,000 | 2,111,941,000 | 2,208,278,000 | 2,181,059,000 | 1,476,637,000 | 1,545,592,000 | 1,623,782,000 | 1,641,486,000 | 1,291,572,000 | 1,283,911,000 | 1,119,222,000 | 1,028,627,000 | 511,773,000 | 379,411,000 | 391,653,000 | 367,720,000 | 383,078,000 | 248,645,000 | 269,345,000 | 288,177,000 | 305,563,000 | 335,232,000 | 396,100,000 | 273,822,000 | 299,520,000 | 220,795,000 | 237,558,000 | 255,840,000 | ||||||||||||||
| liabilities and stockholders’ equity | ||||||||||||||||||||||||||||||||||||||||||||||
| stockholders’ equity: | ||||||||||||||||||||||||||||||||||||||||||||||
| total stockholders’ equity | 1,438,000 | 104,926,000 | 196,577,000 | 292,576,000 | 481,982,000 | 510,954,000 | 572,494,000 | 528,734,000 | 594,330,000 | 663,654,000 | 488,685,000 | 512,942,000 | 350,727,000 | 386,090,000 | 267,402,000 | 150,308,000 | 156,437,000 | 145,882,000 | 169,731,000 | 100,827,000 | 119,583,000 | 140,177,000 | 165,624,000 | 196,001,000 | 269,151,000 | 248,581,000 | 273,320,000 | 201,296,000 | 223,756,000 | 244,342,000 | ||||||||||||||||
| trade receivables | 96,645,000 | 78,801,000 | 94,124,000 | 69,929,000 | 56,786,000 | 53,644,000 | 52,623,000 | 55,538,000 | 60,383,000 | 77,104,000 | 46,350,000 | 67,907,000 | 42,197,000 | 59,383,000 | 45,611,000 | 40,394,000 | 38,744,000 | 33,767,000 | 32,173,000 | 24,929,000 | 27,409,000 | 19,765,000 | 22,618,000 | |||||||||||||||||||||||
| deferred consideration payable | 2,384,000 | 40,000,000 | 19,700,000 | 19,400,000 | 19,300,000 | 38,200,000 | ||||||||||||||||||||||||||||||||||||||||
| deferred revenue- long term | 1,768,000 | |||||||||||||||||||||||||||||||||||||||||||||
| deferred consideration payable- current | 40,000,000 | 19,400,000 | ||||||||||||||||||||||||||||||||||||||||||||
| deferred revenue- long-term | 3,415,000 | |||||||||||||||||||||||||||||||||||||||||||||
| deferred consideration payable- long-term | 18,300,000 | |||||||||||||||||||||||||||||||||||||||||||||
| deferred revenue - long-term | 9,722,000 | 11,156,000 | 10,540,000 | 9,300,000 | 7,954,000 | 6,579,000 | 3,828,000 | 2,194,000 | 1,587,000 | |||||||||||||||||||||||||||||||||||||
| receivables | 8,016,000 | 5,114,000 | 3,178,000 | 1,296,000 | ||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value. undesignated 5,000,000 shares; issued and outstanding 0 shares at september 30, 2014 and december 31, 2013 | ||||||||||||||||||||||||||||||||||||||||||||||
| grant and collaboration receivables | 858,000 | 838,000 | 783,851 | 870,641 | ||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value. undesignated 5,000,000 shares; issued and outstanding 0 shares at june 30, 2014 and december 31, 2013 | ||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value. undesignated 5,000,000 shares; issued and outstanding 0 shares at march 31, 2014 and december 31, 2013 | ||||||||||||||||||||||||||||||||||||||||||||||
| liabilities, convertible preferred stocks and stockholders’ (deficit) equity | ||||||||||||||||||||||||||||||||||||||||||||||
| deferred revenue, less current portion | 241,667 | |||||||||||||||||||||||||||||||||||||||||||||
| long-term debt, less current portion | ||||||||||||||||||||||||||||||||||||||||||||||
| series one convertible preferred stock, designated 2,000,000 shares; issued and outstanding 1,483,337 shares at december 31, 2012 | ||||||||||||||||||||||||||||||||||||||||||||||
| series two convertible preferred stock, designated 13,750,000 shares; issued and outstanding 10,701,405 shares at december 31, 2012 | ||||||||||||||||||||||||||||||||||||||||||||||
| series three convertible preferred stock, designated 13,750,000 shares; issued and outstanding 2,853,517 shares at december 31, 2012 | ||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value. undesignated 5,000,000 shares; issued and outstanding 0 shares at september 30, 2013 | ||||||||||||||||||||||||||||||||||||||||||||||
| total liabilities, convertible preferred stocks and stockholders’ (deficit) equity | 167,244,115 | 175,468,084 | ||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value. undesignated 5,000,000 shares; issued and outstanding 0 shares at june 30, 2013 |
We provide you with 20 years of balance sheets for PTC Therapeutics stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of PTC Therapeutics. Explore the full financial landscape of PTC Therapeutics stock with our expertly curated balance sheets.
The information provided in this report about PTC Therapeutics stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.